The U.S. Vaccine Supply
To the Editor: The National Vaccine Advisory Committee, of which I am a member, agrees with the Institute of Medicine (IOM) vaccine-financing committee 1 that legislative measures and additional funding are needed, but we differ with its recommendations for action, as described by Sloan et al. (Dec....
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2005-03, Vol.352 (10), p.1046-1047 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To the Editor:
The National Vaccine Advisory Committee, of which I am a member, agrees with the Institute of Medicine (IOM) vaccine-financing committee
1
that legislative measures and additional funding are needed, but we differ with its recommendations for action, as described by Sloan et al. (Dec. 2 issue).
2
At the request of the IOM committee, the National Vaccine Advisory Committee convened stakeholder deliberations on vaccine-financing options and concluded that it is not advisable to replace the current system with an insurance mandate and a system of subsidies and vouchers, as the IOM recommends. We are skeptical that such a system . . . |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM200503103521020 |